rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-2-6
|
pubmed:abstractText |
Nesiritide is recombinant human B-type natriuretic peptide, used in the treatment of decompensated heart failure. Ischemic heart disease remains the major underlying cause for congestive heart failure, however, the effects of intravenous and intracoronary nesiritide on coronary circulation have not been adequately studied.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1557-2501
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
76-80
|
pubmed:meshHeading |
pubmed-meshheading:18252972-Animals,
pubmed-meshheading:18252972-Blood Flow Velocity,
pubmed-meshheading:18252972-Coronary Circulation,
pubmed-meshheading:18252972-Coronary Vessels,
pubmed-meshheading:18252972-Echocardiography, Doppler,
pubmed-meshheading:18252972-Infusions, Intravenous,
pubmed-meshheading:18252972-Microcirculation,
pubmed-meshheading:18252972-Natriuretic Agents,
pubmed-meshheading:18252972-Natriuretic Peptide, Brain,
pubmed-meshheading:18252972-Regional Blood Flow,
pubmed-meshheading:18252972-Swine
|
pubmed:year |
2008
|
pubmed:articleTitle |
Effects of B-type natriuretic peptide (nesiritide) on coronary epicardial arteries, systemic vasculature and microvessels.
|
pubmed:affiliation |
Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA. rlaham@bidmc.harvard.edu.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, N.I.H., Extramural
|